Clinical Trials
MindPath Care Centers is pleased to participate in a number of clinical trials from partnered sponsor organizations that pioneer new mental health diagnostics and treatments.
Clinical trials offer a way to evaluate potential new medications, therapies, or tests, under controlled conditions. This important step in medical research helps scientists and healthcare professionals to recognize and develop new treatments for a variety of different medical conditions. All new treatments must go through this evaluation process in order to receive federal approval for the broader healthcare market.
The National Institutes of Health provide a discussion about deciding if participating in a clinical trial may be right for you, and what enrolling in a clinical trial may involve for you as a patient. This information may be found on the NIH website by clicking HERE.
Clinical Trials Available to Patients
This study is designed to evaluate long-term weight changes associated with multi-year risperidone and aripiprazole therapy in children ages 3-18. This study will also provide insights into the overall long-term safety and the effects of both drugs on psychiatric and behavioral symptoms. It will further evaluate long-term development, functioning, and quality of life in children treated with these anti psychotics. Lastly, the sub-study will estimate PK parameters in subsets of young and obese children.
The primary objective of this study is to evaluate the safety and efficacy of brexpiprazole in adults with borderline personality disorder (BPD). The hypothesis to be tested is that brexpiprazole will be more effective and well-tolerated in adults with BPD compared to placebo.